Clinical Trial Update: Tesamorelin for Reduction of Liver Fat in Adults With Fatty Liver Disease (Mock Study) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating tesamorelin to reduce liver fat in adults with metabolic steatotic liver disease and related conditions. The study is currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Steatosis
• Metabolic Dysfunction-associated Steatotic Liver Disease
• Nonalcoholic Steatohepatitis

Drugs mentioned

• Tesamorelin (tesamorelin)

Snippet

Sponsor: Hudson Biotech | Conditions: Metabolic Associated Steatotic Liver Disease, Nonalcoholic Steatohepatitis | Phase 2 | Status: RECRUITING